接受机械通气的危重症成人新发谵妄与短期死亡率的关联
这项单中心前瞻性队列研究在台湾一家大学附属三级医院的6个ICU连续纳入267例接受机械通气的无谵妄危重症成人(中位年龄65.9岁,64.0%为男性),每日用CAM-ICU和RASS评估谵妄与昏迷状态共14天。149例(55.8%)发生谵妄,中位持续3.0天;105例(39.3%)出现昏迷,中位持续3.0天。14天死亡率为18.0%,住院死亡率为42.1%。新发谵妄及谵妄天数与14天死亡率(aHR 1.37,95%CI 0.69-2.72;aHR 1.00,95%CI 0.91-1.10)和住院死亡率(aHR 1.00,95%CI 0.64-1.55;aHR 1.02,95%CI 0.97-1.07)均无关,但昏迷天数与14天死亡率(aHR 1.16,95%CI 1.10-1.22)和住院死亡率(aHR 1.10,95%CI 1.06-1.14)升高相关。每增加1个DCFD,14天死亡风险降低11%(aHR 0.89,95%CI 0.84-0.94),住院死亡风险降低7%(aHR 0.93,95%CI 0.90-0.97)。新发谵妄与住院时间延长相关(校正β=10.80,95%CI 0.53-21.08)。
要点
- 在接受机械通气的危重症成人中,新发谵妄与14天死亡率(aHR 1.37,95%CI 0.69-2.72)和住院死亡率(aHR 1.00,95%CI 0.64-1.55)均无显著关联。
- 昏迷天数与死亡风险升高独立相关:14天死亡率aHR 1.16(95%CI 1.10-1.22),住院死亡率aHR 1.10(95%CI 1.06-1.14)。
- DCFDs为保护因素:每增加1天,14天死亡风险降低11%(aHR 0.89,95%CI 0.84-0.94),住院死亡风险降低7%(aHR 0.93,95%CI 0.90-0.97)。
- 新发谵妄与住院时间延长独立相关(校正β=10.80,95%CI 0.53-21.08),尽管未增加短期死亡率。
- 作者认为,未来研究和干预实施应重新聚焦于最大化DCFDs,以可能改善接受机械通气患者的生存。
适用人群与场景
- 纳入标准:年龄≥20岁、接受机械通气、入ICU时无谵妄的危重症成人;连续纳入自2018年8月14日至2020年10月1日。
- 研究场景:台湾一家大学附属三级医院的6个ICU。
诊断标准与关键阈值
- 谵妄评估:使用ICU意识模糊评估法(CAM-ICU)每日评估。
- 昏迷/镇静深度评估:使用Richmond躁动-镇静评分(RASS)每日评估。
- 评估时长:入住ICU后14天内(或直至死亡或转出ICU)。
研究设计与关键结果
- 研究设计:单中心前瞻性队列研究,纳入267例接受机械通气的无谵妄危重症成人(中位年龄65.9岁,IQR 57.4-75.1;男性171例,64.0%;均为台湾 ethnicity)。
- 暴露:每日评估谵妄和昏迷状态共14天(或直至死亡或转出ICU),使用CAM-ICU和RASS。
- 主要结局:14天死亡率、住院死亡率、住院时间。
- 谵妄发生:149例(55.8%)在入ICU前14天内发生谵妄,中位持续3.0天(IQR 1.0-5.0)。
- 昏迷发生:105例(39.3%)出现昏迷,中位持续3.0天(IQR 1.0-5.0)。
- 死亡率:14天死亡率为18.0%(48例);住院死亡率为42.1%(112/266例,1例退出研究)。
- 谵妄与14天死亡率:新发谵妄aHR 1.37(95%CI 0.69-2.72),谵妄天数aHR 1.00(95%CI 0.91-1.10),均无显著关联。
- 谵妄与住院死亡率:新发谵妄aHR 1.00(95%CI 0.64-1.55),谵妄天数aHR 1.02(95%CI 0.97-1.07),均无显著关联。
证据类型、等级与局限
- 证据类型:单中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来研究和干预实施应重新聚焦于最大化DCFDs,以可能改善接受机械通气患者的生存。
- 原文未据此给出其他推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Intensive care unit (ICU)-acquired delirium and/or coma have consequences for patient outcomes. However, contradictory findings exist, especially when considering short-term (ie, in-hospital) mortality and length of stay (LOS).
OBJECTIVE: To assess whether incident delirium, days of delirium, days of coma, and delirium- and coma-free days (DCFDs) are associated with 14-day mortality, in-hospital mortality, and hospital LOS among patients with critical illness receiving mechanical ventilation.
DESIGN, SETTING, AND PARTICIPANTS: This single-center prospective cohort study was conducted in 6 ICUs of a university-affiliated tertiary hospital in Taiwan. A total of 267 delirium-free patients (aged ≥20 years) with critical illness receiving mechanical ventilation were consecutively enrolled from August 14, 2018, to October 1, 2020.
EXPOSURES: Participants were assessed daily for the development of delirium and coma status over 14 days (or until death or ICU discharge) using the Confusion Assessment Method for the Intensive Care Unit and the Richmond Agitation-Sedation Scale, respectively.
MAIN OUTCOMES AND MEASURES: Mortality rates (14-day and in-hospital) and hospital LOS using electronic health records.
RESULTS: Of 267 participants (median [IQR] age, 65.9 [57.4-75.1] years; 171 men [64.0%]; all of Taiwanese ethnicity), 149 patients (55.8%) developed delirium for a median (IQR) of 3.0 (1.0-5.0) days at some point during their first 14 days of ICU stay, and 105 patients (39.3%) had coma episodes also lasting for a median (IQR) of 3.0 (1.0-5.0) days. The 14-day and in-hospital mortality rates were 18.0% (48 patients) and 42.1% (112 of 266 patients [1 patient withdrew from the study]), respectively. The incidence and days of delirium were not associated with either 14-day mortality (incident delirium: adjusted hazard ratio [aHR], 1.37; 95% CI, 0.69-2.72; delirium by day: aHR, 1.00; 95% CI, 0.91-1.10) or in-hospital mortality (incident delirium: aHR, 1.00; 95% CI, 0.64-1.55; delirium by day: aHR, 1.02; 95% CI, 0.97-1.07), whereas days spent in coma were associated with an increased hazard of dying during a given 14-day period (aHR, 1.16; 95% CI, 1.10-1.22) and during hospitalization (aHR, 1.10; 95% CI, 1.06-1.14). The number of DCFDs was a protective factor; for each additional DCFD, the risk of dying during the 14-day period was reduced by 11% (aHR, 0.89; 95% CI, 0.84-0.94), and the risk of dying during hospitalization was reduced by 7% (aHR, 0.93; 95% CI, 0.90-0.97). Incident delirium was associated with longer hospital stays (adjusted β = 10.80; 95% CI, 0.53-21.08) when compared with no incident delirium.
CONCLUSIONS AND RELEVANCE: In this study, despite prolonged LOS, ICU delirium was not associated with short-term mortality. However, DCFDs were associated with a lower risk of dying, suggesting that future research and intervention implementation should refocus on maximizing DCFDs to potentially improve the survival of patients receiving mechanical ventilation.
参考来源
- Li HC, Yeh TY, Wei YC, et al. Association of Incident Delirium With Short-term Mortality in Adults With Critical Illness Receiving Mechanical Ventilation. JAMA Netw Open. 2022. PMID: 36205994. doi:10.1001/jamanetworkopen.2022.35339
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。